scanX
Home
Orchid Pharma

Orchid Pharma

1,458.35
-19.25
(-1.30%)
Market Cap (₹ Cr.)
₹7,471
52 Week High
1,590.00
Book Value
₹231
52 Week Low
556.85
PE Ratio
62.79
PB Ratio
6.10
PE for Sector
37.00
PB for Sector
3.92
ROE
8.13 %
ROCE
8.37 %
Dividend Yield
0.00 %
EPS
₹21.99
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
24.06 %
Net Income Growth
72.07 %
Cash Flow Change
586.97 %
ROE
1.33 %
ROCE
17.50 %
EBITDA Margin (Avg.)
10.71 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
305
256
214
206
219
195
190
192
214
140
214
153
157
145
156
150
188
141
138
136
116
120
109
104
123
99
176
162
182
134
171
169
251
185
207
228
230
252
231
Expenses
367
209
184
167
175
267
165
161
259
167
186
131
148
145
146
136
170
145
131
138
138
97
91
108
118
94
114
144
153
119
147
146
171
161
175
185
188
211
193
EBITDA
-62
47
30
39
44
-72
25
31
-45
-27
28
22
9
0
10
14
18
-4
7
-2
-22
24
18
-4
5
5
62
18
29
15
24
23
80
24
32
43
42
41
38
Operating Profit %
-30 %
18 %
12 %
18 %
16 %
-47 %
12 %
11 %
-27 %
-24 %
11 %
9 %
5 %
-11 %
-2 %
8 %
-5 %
-7 %
-0 %
-7 %
-25 %
19 %
16 %
-5 %
2 %
2 %
6 %
10 %
15 %
10 %
11 %
9 %
18 %
12 %
12 %
16 %
13 %
14 %
13 %
Depreciation
60
37
36
36
35
35
35
35
35
34
34
33
33
33
33
33
31
31
32
32
31
30
30
29
20
20
20
20
27
22
18
8
7
8
8
9
8
8
9
Interest
105
71
76
76
71
72
71
73
120
71
75
76
79
14
0
0
0
0
0
1
1
14
13
13
12
11
10
7
4
8
9
8
7
6
4
4
3
3
3
Profit Before Tax
-227
-60
-81
-73
-63
-179
-81
-77
-200
-131
-81
-88
-103
-46
-23
-18
-13
-36
-25
-35
-54
-20
-25
-45
-27
-26
32
-9
-2
-14
-3
7
65
11
20
31
30
29
26
Tax
-79
-13
-12
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
-148
-48
-69
-94
-64
-167
-69
-65
-188
-114
-70
-77
-92
-46
-23
-18
-13
-36
-25
-35
-54
-20
-25
-45
-27
-26
32
-9
-2
-14
-3
7
65
11
20
31
33
29
26
EPS in ₹
-17.36
-5.58
-8.09
-10.57
-7.32
-18.73
-7.76
-7.26
-21.16
-12.87
-7.91
-8.68
-10.38
-5.17
-2.60
-2.08
-1.51
-4.00
-2.83
-3.91
-13.31
-4.81
-6.12
-11.11
-6.67
-6.38
7.84
-2.08
-0.44
-3.45
-0.81
1.65
15.89
2.64
4.40
6.42
6.86
5.74
5.05
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
4,156
3,963
3,358
3,211
2,993
1,450
1,224
1,094
1,223
1,552
Fixed Assets
1,697
1,540
1,402
1,291
1,161
858
670
584
573
616
Current Assets
1,347
1,324
703
691
783
565
542
383
494
782
Capital Work in Progress
282
280
288
272
278
26
7
10
46
24
Investments
0
0
125
125
0
0
15
49
50
69
Other Assets
2,177
2,142
1,543
1,523
1,553
566
531
452
554
842
Total Liabilities
3,717
3,791
3,701
3,885
3,748
652
543
416
491
334
Current Liabilities
1,107
1,316
1,489
1,980
2,313
133
101
194
327
210
Non Current Liabilities
2,610
2,475
2,212
1,905
1,436
519
442
222
165
124
Total Equity
439
171
-343
-674
-755
798
681
678
732
1,218
Reserve & Surplus
354
82
-432
-763
-844
757
641
637
691
1,168
Share Capital
85
89
89
89
89
41
41
41
41
51
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
367
-76
-239
11
60
-3
-73
-14
18
-18
Investing Activities
1,334
-1
-176
-28
45
167
67
113
-27
-316
Operating Activities
46
211
402
6
15
80
24
90
13
131
Financing Activities
-597
-287
-465
33
-0
-250
-165
-217
31
167
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
98.07 %
90.00 %
90.00 %
90.00 %
90.00 %
89.96 %
89.96 %
89.96 %
89.96 %
72.40 %
72.40 %
69.84 %
69.84 %
69.84 %
69.84 %
FIIs
0.01 %
1.79 %
1.79 %
1.78 %
1.61 %
1.48 %
1.37 %
0.86 %
0.81 %
0.45 %
8.08 %
4.14 %
1.96 %
1.42 %
1.94 %
DIIs
1.03 %
3.71 %
3.35 %
3.35 %
2.97 %
2.97 %
2.98 %
3.94 %
2.62 %
21.61 %
12.47 %
14.50 %
17.73 %
18.93 %
18.29 %
Government
0.00 %
0.00 %
0.04 %
0.04 %
0.04 %
0.04 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.89 %
4.51 %
4.83 %
4.84 %
5.39 %
5.55 %
5.68 %
5.23 %
6.60 %
5.53 %
7.06 %
11.53 %
10.47 %
9.81 %
9.93 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,795.30 4,26,517.78 38.05 49,887.17 12.06 9,648 27.35 44.59
Cipla
1,486.50 1,18,365.23 25.64 26,520.66 14.17 4,155 12.95 41.66
Mankind Pharma
2,551.60 1,02,273.02 48.35 10,615.63 19.57 1,942 28.89 44.48
Dr Reddys Laboratories
1,214.45 99,671.43 18.67 28,905.40 12.36 5,578 -9.47 36.74
Zydus Life Science
949.05 95,013.64 22.21 19,831.50 13.82 3,831 14.57 33.61
Lupin
2,071.35 93,214.31 35.49 20,141.50 19.94 1,936 73.52 42.68
Aurobindo Pharma
1,223.70 71,496.23 19.60 29,559.25 17.55 3,169 8.65 19.57
Alkem Laboratories
5,583.35 66,992.27 30.81 12,978.42 9.84 1,811 14.16 39.72
Glenmark Pharmaceuticals
1,478.20 41,349.03 - 12,653.09 6.58 -1,831 675.84 30.06
IPCA Laboratories
1,591.35 39,912.75 59.43 7,829.81 22.92 529 80.05 55.08

Corporate Action

Technical Indicators

RSI(14)
Neutral
55.05
ATR(14)
Volatile
68.67
STOCH(9,6)
Neutral
41.17
STOCH RSI(14)
Neutral
33.73
MACD(12,26)
Bullish
1.78
ADX(14)
Weak Trend
11.61
UO(9)
Bearish
46.19
ROC(12)
Uptrend And Accelerating
4.94
WillR(14)
Neutral
-46.59
Bearish
2
Neutral
5
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.